1. Home
  2. SLNO vs WSBC Comparison

SLNO vs WSBC Comparison

Compare SLNO & WSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • WSBC
  • Stock Information
  • Founded
  • SLNO 1999
  • WSBC 1870
  • Country
  • SLNO United States
  • WSBC United States
  • Employees
  • SLNO N/A
  • WSBC N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • WSBC Major Banks
  • Sector
  • SLNO Health Care
  • WSBC Finance
  • Exchange
  • SLNO Nasdaq
  • WSBC Nasdaq
  • Market Cap
  • SLNO 1.9B
  • WSBC 2.1B
  • IPO Year
  • SLNO 2014
  • WSBC N/A
  • Fundamental
  • Price
  • SLNO $49.17
  • WSBC $31.97
  • Analyst Decision
  • SLNO Strong Buy
  • WSBC Buy
  • Analyst Count
  • SLNO 6
  • WSBC 4
  • Target Price
  • SLNO $74.83
  • WSBC $36.75
  • AVG Volume (30 Days)
  • SLNO 567.7K
  • WSBC 443.9K
  • Earning Date
  • SLNO 03-05-2025
  • WSBC 01-22-2025
  • Dividend Yield
  • SLNO N/A
  • WSBC 4.63%
  • EPS Growth
  • SLNO N/A
  • WSBC N/A
  • EPS
  • SLNO N/A
  • WSBC 2.09
  • Revenue
  • SLNO N/A
  • WSBC $566,976,000.00
  • Revenue This Year
  • SLNO N/A
  • WSBC N/A
  • Revenue Next Year
  • SLNO N/A
  • WSBC $68.60
  • P/E Ratio
  • SLNO N/A
  • WSBC $15.30
  • Revenue Growth
  • SLNO N/A
  • WSBC N/A
  • 52 Week Low
  • SLNO $36.61
  • WSBC $25.56
  • 52 Week High
  • SLNO $60.92
  • WSBC $37.36
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 56.57
  • WSBC 44.00
  • Support Level
  • SLNO $45.44
  • WSBC $31.44
  • Resistance Level
  • SLNO $49.03
  • WSBC $32.57
  • Average True Range (ATR)
  • SLNO 2.36
  • WSBC 0.74
  • MACD
  • SLNO 0.66
  • WSBC 0.07
  • Stochastic Oscillator
  • SLNO 98.40
  • WSBC 68.08

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.

About WSBC WesBanco Inc.

Wesbanco Inc is a bank holding company that offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. The company has two reportable segments: community banking and trust and investment services. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. Its market service area primarily includes the Rust Belt region of the United States. Commercial real estate accounts for nearly half of the bank's loan portfolio. The bank has historically grown through both organic growth and acquisitions. The bank's primary component of net revenue is net interest income.

Share on Social Networks: